| Financial Year |
March 31 2023 |
| Monetary Funds |
1,230,407,399.68 |
| Held-for-trading Financial Assets |
904,823,072.83 |
| Notes Receivable |
6,388,703.39 |
| Accounts Receivable |
-- |
| Advances to Suppliers |
12,084,440.01 |
| Other Receivables |
47,500.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
367,626,620.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
245,021,967.68 |
| Total Current Assets |
2,776,399,704.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,534,705,989.74 |
| Under-construction Projects |
2,115,951,790.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
223,391,863.48 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,208,655.97 |
| Other Non-Current Assets |
1,690,356,833.44 |
| Sub-Total of Non-Current Assets |
7,567,615,133.53 |
| Total Assets |
10,344,014,837.65 |
| Short-Term Loans |
573,388,703.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
699,671,141.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
35,877,188.34 |
| Taxes Payable |
4,919,625.40 |
| Interest Payable |
-- |
| Dividend Payable |
91,300,000.00 |
| Other payables |
94,365,959.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
6,626,241.62 |
| Sub-Total of Current Liabilities |
1,465,819,948.44 |
| Long-term Loans |
201,273,255.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,374,490.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
297,516,442.71 |
| Total Liabilities |
1,763,336,391.15 |
| Paid-In Capital(Or Share Stock) |
550,000,000.00 |
| Capital Surplus |
4,391,615,206.84 |
| Surplus Reserve |
328,884,240.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,287,691,824.15 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,580,678,446.50 |
| Owner's Equity（Stockholder's Equity） |
8,580,678,446.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,344,014,837.65 |
